1. Home
  2. VCEL vs BBUC Comparison

VCEL vs BBUC Comparison

Compare VCEL & BBUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • BBUC
  • Stock Information
  • Founded
  • VCEL 1989
  • BBUC 2022
  • Country
  • VCEL United States
  • BBUC United States
  • Employees
  • VCEL N/A
  • BBUC N/A
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • BBUC
  • Sector
  • VCEL Health Care
  • BBUC
  • Exchange
  • VCEL Nasdaq
  • BBUC Nasdaq
  • Market Cap
  • VCEL 2.1B
  • BBUC 2.2B
  • IPO Year
  • VCEL 1997
  • BBUC N/A
  • Fundamental
  • Price
  • VCEL $35.61
  • BBUC $30.83
  • Analyst Decision
  • VCEL Strong Buy
  • BBUC
  • Analyst Count
  • VCEL 7
  • BBUC 0
  • Target Price
  • VCEL $61.29
  • BBUC N/A
  • AVG Volume (30 Days)
  • VCEL 614.9K
  • BBUC 94.8K
  • Earning Date
  • VCEL 07-31-2025
  • BBUC 08-01-2025
  • Dividend Yield
  • VCEL N/A
  • BBUC 0.84%
  • EPS Growth
  • VCEL 2045.40
  • BBUC N/A
  • EPS
  • VCEL 0.13
  • BBUC N/A
  • Revenue
  • VCEL $249,119,000.00
  • BBUC $8,240,000,000.00
  • Revenue This Year
  • VCEL $23.03
  • BBUC N/A
  • Revenue Next Year
  • VCEL $24.51
  • BBUC N/A
  • P/E Ratio
  • VCEL $284.01
  • BBUC N/A
  • Revenue Growth
  • VCEL 16.13
  • BBUC 6.96
  • 52 Week Low
  • VCEL $33.09
  • BBUC $20.23
  • 52 Week High
  • VCEL $63.00
  • BBUC $32.47
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 42.13
  • BBUC 50.48
  • Support Level
  • VCEL $35.24
  • BBUC $28.29
  • Resistance Level
  • VCEL $38.08
  • BBUC $31.24
  • Average True Range (ATR)
  • VCEL 1.85
  • BBUC 0.92
  • MACD
  • VCEL -0.03
  • BBUC -0.07
  • Stochastic Oscillator
  • VCEL 27.62
  • BBUC 48.30

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About BBUC Brookfield Business Corporation Exchangeable Subordinate Voting Shares

Brookfield Business Corp is a company established as a vehicle that owns and operates certain services and industrial operations on a world-wide basis and an alternative vehicle for investors who prefer investing in its operations through a corporate structure. Its goal is to generate returns through long-term capital appreciation with a modest distribution yield.

Share on Social Networks: